Main public logs

Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

16:53, 14 February 2024 Fire talk contribs created page complications of diabetes mellitus (Q20968) (wbeditentity-create:2|en: complications of diabetes mellitus, medical conditions)
16:53, 14 February 2024 Fire talk contribs created page ocular manifestation of diabetes (Q20967) (wbeditentity-create:2|en: ocular manifestation of diabetes, Human disease)
16:52, 14 February 2024 Fire talk contribs created page diabetic retinopathy (Q20966) (wbeditentity-create:2|en: diabetic retinopathy, human disease)
16:49, 14 February 2024 Fire talk contribs created page Template:Wdib (Created page with "{{#invoke:WikidataIB|getValue}}<noinclude> {{documentation}} </noinclude>")
16:49, 14 February 2024 Fire talk contribs created page Template:ICD9 (Created page with "[http://www.icd9data.com/getICD9Code.ashx?icd9={{{1}}} {{{1}}}]<noinclude> {{documentation}} </noinclude>")
16:48, 14 February 2024 Fire talk contribs created page Template:ICD10 (Created page with "{{#if:{{{1|}}}|[https://icd.who.int/browse10/2019/en#/{{{1|}}}{{{2|}}}{{#if:{{{3|}}}|.{{{3}}}}} {{{1|}}}{{{2|}}}{{#if:{{{3|}}}|.{{{3}}}}}]}}<noinclude> {{Documentation}}  </noinclude>")
16:48, 14 February 2024 Fire talk contribs created page Template:EMedicine2 (Created page with "{{#ifeq: {{{1}}}|article|[https://emedicine.medscape.com/article/{{{2}}}-{{{4|overview}}}|[https://www.emedicine.com/{{{1}}}/topic{{{2}}}.htm#{{#if: {{{4|}}}|section~{{{4}}}}}}} {{{3|{{{1}}}/{{{2}}}}}}{{#if: {{{4|}}}|~{{{4}}}}}]<noinclude> {{documentation}} </noinclude>")
16:47, 14 February 2024 Fire talk contribs created page Template:Transclude (Created page with "{{#switch: {{NAMESPACE: {{{1}}} }} |#default = {{FULLPAGENAME: {{{1}}} }}  |{{ns:0}} =  {{#if: {{#invoke:string2|startswith|1={{{1|}}}|2=:}} |{{PAGENAME: {{{1}}} }}  |Template:{{{1}}}  }} }}...")
16:47, 14 February 2024 Fire talk contribs created page Template:Ed (Created page with "[{{fullurl:{{transclude|{{{1}}}}}|action=edit}} {{#if:{{{2|}}}|{{{2|}}}|edit}}]<noinclude> {{documentation}}</noinclude>")
16:46, 14 February 2024 Fire talk contribs created page Template:Template reference list (Created page with "{{#if:{{NAMESPACE}}|<h2>References</h2> {{Hatnote|These references will appear in the article, but this list appears only on this page.}} {{#tag:references|{{{refs|}}}|responsive=1}} {{#if:{{{1|}}}| {{Hatnote|The references of group "{{{1}}}":}} {{#tag:references|{{{refs|}}}|group={{{1}}}|responsive=1}}}} {{#if:{{{2|}}}| {{Hatnote|The references of group "{{{2}}}":}} {{#tag:references|{{{refs|}}}|group={{{2}}}|responsive=1}}}} {{#if:{{{3|}}}| {{Hatnote|The references of...")
16:46, 14 February 2024 Fire talk contribs created page Template:OGTT (Created page with "{| class="wikitable" style = "float: right; margin-left:15px; text-align:center" |+ WHO diabetes diagnostic criteria<ref name=who2006>{{cite book |title=Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation |url=http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf |publisher=World Health Organization |location=Geneva |page=21 |year=2006 |isbn= 978-92-4-159493-6}}</ref><r...")
16:46, 14 February 2024 Fire talk contribs created page Template:Medical condition classification and resources (Created page with "<noinclude>{{short description|Displays important medical data that is not relevant to a general reader}}</noinclude>{{navbox | bodystyle=width:100%; margin:0.5em 0 0.5em 0; | groupstyle= background: #EAECF0  | group1 = Classification | list1 = <div style="position:relative; float:right; font-size:0.8em;">[[d:{{#if:{{{QID|}}} |{{{QID|}}} |{{#invoke:WikidataIB|pageId}}}} |D]]</div>{{hlist |style=t...")
16:45, 14 February 2024 Fire talk contribs created page Template:Col-float/styles.css (Created page with "@media all and ( max-width: 720px ) { .multicol-float { width: auto !important; } } .multicol-float { width: 30em; clear: none; float: left; } .multicol-float-clear { clear: both; }")
16:45, 14 February 2024 Fire talk contribs created page Template:Col-float-begin (Redirected page to Template:Col-float) Tag: New redirect
16:44, 14 February 2024 Fire talk contribs created page Template:Disease of the pancreas and glucose metabolism (Created page with "{{Navbox | name = Disease of the pancreas and glucose metabolism | title = Disease of the pancreas and glucose metabolism | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = Diabetes | list1 = * Types ** type 1 ** type 2 ** gestational ** MODY ...")
16:43, 14 February 2024 Fire talk contribs created page Diabetes (Created page with "{{short description|Group of endocrine diseases characterized by high blood sugar levels}} {{About|the common insulin disorder|the urine hyper-production disorder|Diabetes insipidus|other uses|Diabetes (disambiguation)}} {{Infobox medical condition (new) | name = Diabetes mellitus | pronounce = {{IPAc-en|ˌ|d|aɪ|_|ə|'|b|i|_|t|i|z|,_|-|t|I|s}} | image = Blue circle for diabetes.svg | image_size = 250px | alt = A hollow circle with a thi...")
16:11, 14 February 2024 Fire talk contribs created page Diabetes mellitus/ja (Redirected page to 糖尿病) Tag: New redirect
16:11, 14 February 2024 Fire talk contribs created page Diabetes mellitus (Redirected page to Diabetes) Tag: New redirect
16:09, 14 February 2024 Fire talk contribs created page Template:Drug design/ja (Created page with "{{Navbox |name = Drug design/ja |title = 薬物設計 |listclass = hlist |state = autocollapse |group1 = 設計のステップ |list1 = * Drug discovery/ja * Hit to lead/ja * Drug development/ja ** 前臨床 ** 臨床 *** フェーズ |group2 = 薬物クラスの発見と 開発のケーススタディ |list2 = * Discovery and development of 5α...")
15:58, 14 February 2024 Fire talk contribs created page formic acid exposure (Q20965) (wbeditentity-create:2|en: formic acid exposure, hazardous chemical exposure)
15:57, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/37/ja (Created page with "Gliflozins ")
15:57, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/36/ja (Created page with "{{Drug design/ja}}")
15:57, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/35/ja (Created page with "== こちらも参照 == * Sodium-glucose transport proteins/ja * SLC5A2/ja * SGLT1/ja * SGLT2/ja * Dapagliflozin/ja * Empagliflozin/ja * Canagliflozin/ja * イプラグリフロジン")
15:56, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/34/ja (Created page with "'''表3：'''チアゾール環の関わり方によるIC50値の違い（他の構造は何も変えていない（X = Cl, R = フェニルと2-フリル）。 {| class="wikitable" |- ! 化合物 !! IC50 (nM) |- |align="center"| File:Mynd fyrir toflu3-1.png ||align="center"| 0.720 |- |align="center"| File:Mynd fyrir toflu3-2.png ||align="center"| 1.11 |}")
15:55, 14 February 2024 Fire talk contribs created page alkanoic acid (Q20964) (wbeditentity-create:2|en: alkanoic acid, any carboxylic acid consisting of carboxylic group and alkyl only)
15:54, 14 February 2024 Fire talk contribs created page formic acid (Q20963) (wbeditentity-create:2|en: formic acid, chemical compound)
15:53, 14 February 2024 Fire talk contribs created page response to formic acid (Q20962) (wbeditentity-create:2|en: response to formic acid, Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a formic acid stimulus.)
15:52, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/33/ja (Created page with "{| class="wikitable" |- ! X!! IC50 (nM) |- |align="center"| Cl ||align="center"| 0.720 |- |align="center"| Me ||align="center"| 1.43 |- |align="center"| F ||align="center"| 6.11 |- |align="center"| H ||align="center"| 22.6 |- |align="center"| CN ||align="center"| 36.7 |}")
15:52, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/32/ja (Created page with "File:Mynd fyrir toflu2.png")
15:52, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/31/ja (Created page with "'''表2：'''近位フェニル環のC-4領域にどの化合物があるかによる'''試験管内'''活性の違い。")
15:51, 14 February 2024 Fire talk contribs created page 2-amino-5-formylamino-6-(5-phosphoribosylamino)pyrimidin-4(3H)-one formate-lyase activity (Q20961) (wbeditentity-create:2|en: 2-amino-5-formylamino-6-(5-phosphoribosylamino)pyrimidin-4(3H)-one formate-lyase activity, Catalysis of the reaction: 2-amino-5-formylamino-6-(5-phosphoribosylamino)pyrimidin-4(3H)-one + H2O = 2,5-diamino-6-(5-phosphoribosylamino)pyrimidin-4(3H)-one + formate.)
15:50, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/30/ja (Created page with "表2において、''試験管内''活性は、近位フェニル環（X）のC-4領域の化合物によって変化する。C-4位に小さなメチル基や他のハロゲン原子があると、IC50は0.72-36.7の範囲になった（2-フリルを持つフェニルが環の位置にあることを考慮）。")
15:50, 14 February 2024 Fire talk contribs created page oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor (Q20960) (wbeditentity-create:2|en: oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor, Catalysis of an oxidation-reduction (redox) reaction in which a CH2 group acts as a hydrogen or electron donor and reduces a quinone or similar acceptor molecule.)
15:49, 14 February 2024 Fire talk contribs created page formate dehydrogenase (quinone) activity (Q20959) (wbeditentity-create:2|en: formate dehydrogenase (quinone) activity, Catalysis of the reaction: formate + a quinone = CO2 + a quinol.)
15:48, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/29/ja (Created page with "{| class="wikitable" |- ! R !! IC50 (nM) !! 活性 |- |align="center"| File:Bygging 1.png ||align="center"| 0.720 ||align="center"| ''試験管内''活性が向上* |- |align="center"| File:Bygging 2.png ||align="center"| 1.14 ||align="center"| ''試験管内''活性が向上* |- |align="center"| File:Bygging 3.png ||align="center"| 13.3 ||align="center"| 炭素数が増えるにつれて、IC-50値は変動 |- |align="center"| File:1-Methoxy-n-b...")
15:46, 14 February 2024 Fire talk contribs created page fluorescent chlorophyll catabolite monooxygenase (deformylase) activity (Q20958) (wbeditentity-create:2|en: fluorescent chlorophyll catabolite monooxygenase (deformylase) activity, Catalysis of the reaction: O2 + primary fluorescent chlorophyll catabolite + reduced [NADPH--hemoprotein reductase] = formate + 2 H+ + oxidized [NADPH--hemoprotein reductase] + primary fluorescent dioxobilin-type chlorophyll catabolite.)
15:44, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/28/ja (Created page with "File:Mynd fyrir toflu1.png")
15:44, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/27/ja (Created page with "'''表1：'''遠位環に結合する化合物による'''試験管内'''活性の違い。")
15:43, 14 February 2024 Fire talk contribs created page hydroxymethyl-, formyl- and related transferase activity (Q20957) (wbeditentity-create:2|en: hydroxymethyl-, formyl- and related transferase activity, Catalysis of the transfer of a hydroxymethyl- or formyl group from one compound (donor) to another (acceptor).)
15:42, 14 February 2024 Fire talk contribs created page phosphoribosylglycinamide formyltransferase 2 activity (Q20956) (wbeditentity-create:2|en: phosphoribosylglycinamide formyltransferase 2 activity, Catalysis of the reaction: formate + ATP + 5'-phospho-ribosylglycinamide = 5'-phosphoribosyl-N-formylglycinamide + ADP + diphosphate.)
15:41, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/26/ja (Created page with "多くの化合物が''試験管内'活性において、環の位置で異なるIC50値を示した。例えば、n-ペンチル基（IC50 = 13,3 nM）、n-ブチル基（IC50 = 119 nM）、2-フリル基を持つフェニル基（IC50 = 0,720）または3-チオフェニル基（IC50 = 0,772）には大きな違いがあった。表1に見られるように、''試験管内''活性は、（近位フ...")
15:37, 14 February 2024 Fire talk contribs created page formate dehydrogenase (cytochrome) activity (Q20955) (wbeditentity-create:2|en: formate dehydrogenase (cytochrome) activity, Catalysis of the reaction: formate + ferricytochrome b1 = CO2 + ferrocytochrome b1.)
15:36, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/25/ja (Created page with "ソン(Song)たちはカルボン酸からチアゾール化合物を調製した。チアゾール環を持つダパグリフロジンのような化合物を得るには、3つのステップが必要だった。化合物のSGLT-2に対する阻害作用が、ソンと彼の共同研究者らによって試験された。表1、2、3において、IC50値は、どの化合物が環の位置にあるか、近位フェニル環のC-4領域にあるか、チア...")
15:34, 14 February 2024 Fire talk contribs created page N-substituted formamide deformylase activity (Q20954) (wbeditentity-create:2|en: N-substituted formamide deformylase activity, Catalysis of the reaction: N-benzylformamide + H2O = formate + benzylamine.)
15:34, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/24/ja (Created page with "T-1095の発見を契機に、グリコシド・コアに様々な置換基を付加することにより、効力、選択性、経口バイオアベイラビリティを向上させる方法が研究されるようになった。一例として、グルコースとアグリコン部分の間に炭素-炭素結合を作ることによって、o-グリコシドをc-グリコシドに変化させることができる。C-グルコシドはo-グルコシドよりも安定...")
15:32, 14 February 2024 Fire talk contribs created page aldehyde oxygenase (deformylating) activity (Q20953) (wbeditentity-create:2|en: aldehyde oxygenase (deformylating) activity, Catalysis of the reaction a long-chain aldehyde + O(2) + 2 NADPH = an alkane + formate + H(2)O + 2 NADP(+).)
15:32, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/23/ja (Created page with "== 構造活性相関（SAR）== {{Anchor|Structure-activity relationship (SAR)}} フロリジンおよびダパグリフロジンのアグリコンは、SGLT-1およびSGLT-2に対して弱い阻害作用を有する。阻害剤とSGLTの結合には2つのシナジー力が関与している。アグリコン上の異なる糖は、アクセス前庭におけるアグリコンの向きに影響を与え、変化させる。...")
15:30, 14 February 2024 Fire talk contribs created page N-formylglutamate deformylase activity (Q20952) (wbeditentity-create:2|en: N-formylglutamate deformylase activity, Catalysis of the reaction: N-formyl-L-glutamate + H(2)O = L-glutamate + formate.)
15:29, 14 February 2024 Fire talk contribs created page Translations:Discovery and development of gliflozins/22/ja (Created page with "カナグリフロジンを検討したメタアナリシスの結果、カナグリフロジンはプラセボと比較してHbA1cに影響を及ぼすことが示された。また、エンパグリフロジンの10 mgと25 mgは、プラセボと比較してHbA1cを改善することがメタアナリシス研究で示された。")
15:28, 14 February 2024 Fire talk contribs created page N,N-dimethylformamidase activity (Q20951) (wbeditentity-create:2|en: N,N-dimethylformamidase activity, Catalysis of the reaction: N,N-dimethylformamide + H(2)O = dimethylamine + formate.)

Main public logs

Navigation menu

Search